Cargando…

The spectrum of pediatric amplified musculoskeletal pain syndrome

BACKGROUND: Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherry, David D., Sonagra, Maitry, Gmuca, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552512/
https://www.ncbi.nlm.nih.gov/pubmed/33046102
http://dx.doi.org/10.1186/s12969-020-00473-2
_version_ 1783593415754121216
author Sherry, David D.
Sonagra, Maitry
Gmuca, Sabrina
author_facet Sherry, David D.
Sonagra, Maitry
Gmuca, Sabrina
author_sort Sherry, David D.
collection PubMed
description BACKGROUND: Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia. METHODS: We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale. RESULTS: We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001). CONCLUSIONS: There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population.
format Online
Article
Text
id pubmed-7552512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75525122020-10-13 The spectrum of pediatric amplified musculoskeletal pain syndrome Sherry, David D. Sonagra, Maitry Gmuca, Sabrina Pediatr Rheumatol Online J Research Article BACKGROUND: Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia. METHODS: We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale. RESULTS: We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001). CONCLUSIONS: There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population. BioMed Central 2020-10-12 /pmc/articles/PMC7552512/ /pubmed/33046102 http://dx.doi.org/10.1186/s12969-020-00473-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sherry, David D.
Sonagra, Maitry
Gmuca, Sabrina
The spectrum of pediatric amplified musculoskeletal pain syndrome
title The spectrum of pediatric amplified musculoskeletal pain syndrome
title_full The spectrum of pediatric amplified musculoskeletal pain syndrome
title_fullStr The spectrum of pediatric amplified musculoskeletal pain syndrome
title_full_unstemmed The spectrum of pediatric amplified musculoskeletal pain syndrome
title_short The spectrum of pediatric amplified musculoskeletal pain syndrome
title_sort spectrum of pediatric amplified musculoskeletal pain syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552512/
https://www.ncbi.nlm.nih.gov/pubmed/33046102
http://dx.doi.org/10.1186/s12969-020-00473-2
work_keys_str_mv AT sherrydavidd thespectrumofpediatricamplifiedmusculoskeletalpainsyndrome
AT sonagramaitry thespectrumofpediatricamplifiedmusculoskeletalpainsyndrome
AT gmucasabrina thespectrumofpediatricamplifiedmusculoskeletalpainsyndrome
AT sherrydavidd spectrumofpediatricamplifiedmusculoskeletalpainsyndrome
AT sonagramaitry spectrumofpediatricamplifiedmusculoskeletalpainsyndrome
AT gmucasabrina spectrumofpediatricamplifiedmusculoskeletalpainsyndrome